Goldman Sachs
LNAI

Goldman Sachs’s Lunai Bioworks LNAI Stock Holding History

Goldman Sachs’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,510
Closed -$4.92K – 6922
2026
Q1 		$4.92K Buy
1,510
+151
+11% +$750 ﹤0.01% 6399
2025
Q4 		$9.58K Sell
1,359
-444
-25% -$3.97K ﹤0.01% 6368
2025
Q3 		$20.5K Sell
1,803
-5,634
-76% -$109K ﹤0.01% 6234
2025
Q2 		$172K Buy
7,437
+5,161
+227% +$144K ﹤0.01% 5701
2025
Q1 		$98.9K Sell
2,276
-2,280
-50% -$146K ﹤0.01% 5787
2024
Q4 		$305K Buy
4,556
+3,395
+292% +$225K ﹤0.01% 5487
2024
Q3 		$44.9K Buy
1,161
+423
+57% +$29.3K ﹤0.01% 5640
2024
Q2 		$103K Sell
738
-3,089
-81% -$421K ﹤0.01% 5398
2024
Q1 		$811K Buy
3,827
+3,666
+2,277% +$989K ﹤0.01% 4473
2023
Q4 		$40.8K Buy
+161
New +$44.1K ﹤0.01% 5400
2023
Q3 		– Sell
-1,476
Closed -$66.9K – 5806
2023
Q2 		$66.9K Buy
1,476
+1,303
+753% +$100K ﹤0.01% 5422
2023
Q1 		$12.7K Buy
+173
New +$15.2K ﹤0.01% 5715
2022
Q2 		– Sell
-1,036
Closed -$684K – 6665
2022
Q1 		$684K Buy
1,036
+216
+26% +$115K ﹤0.01% 5124
2021
Q4 		$478K Buy
820
+504
+159% +$366K ﹤0.01% 5419
2021
Q3 		$170K Sell
316
-215
-40% -$105K ﹤0.01% 5776
2021
Q2 		$211K Sell
531
-162
-23% -$52.8K ﹤0.01% 5715
2021
Q1 		$196K Buy
+693
New +$204K ﹤0.01% 5654
2019
Q3 		– Sell
-203
Closed -$73K – 5349
2019
Q2 		$73K Sell
203
-1,210
-86% -$590K ﹤0.01% 4978
2019
Q1 		$784K Buy
+1,413
New +$826K ﹤0.01% 4192

Other funds holding LNAI

GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Goldman Sachs's LNAI Position: Q2 2026 in Review

Goldman Sachs sold out of Lunai Bioworks (LNAI) in Q2 2026, closing a stake of 1,510 shares — an estimated $4.92K sold.

Goldman Sachs first reported a position in LNAI in Q1 2019 and held it in 19 quarters. The position peaked at $811K in Q1 2024. 15 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

  • Goldman Sachs reported no remaining Lunai Bioworks position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 1,510 Lunai Bioworks shares in Q2 2026, an estimated $4.92K.
  • Goldman Sachs first reported a position in Lunai Bioworks in Q1 2019 and held it in 19 quarters.
  • Goldman Sachs's Lunai Bioworks position peaked at $811K in Q1 2024.
  • 15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.